Stay updated on Extension of AK002 in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.4.2. Removed older notices including the lapse in government funding message and Revision: v3.4.1.SummaryDifference0.4%

- Check10 days agoChange DetectedA government funding status notice was added to the page and the revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check17 days agoChange DetectedAdded a Show glossary option and updated revision/QC metadata (Last Update Submitted that Met QC Criteria, Revision: v3.4.0), while removing the previous QC label and No FEAR Act data.SummaryDifference0.2%

- Check31 days agoChange DetectedRevision history updated to include v3.3.4 and remove v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedA consolidated 'Locations' section has been added listing study sites across Arizona, California, Florida, Illinois, Iowa, Maryland, Massachusetts, Minnesota, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and Utah, and the revision tag shows v3.3.3.SummaryDifference2%

- Check82 days agoChange DetectedThe page shows a new site revision (v3.3.2) added and the previous revision (v3.2.0) removed, which seems to be a maintenance update rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Extension of AK002 in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page.